Jefferson Parish Opioid Settlement Money and the New Drug Court

Local officials in Jefferson Parish want to spend opioid settlement money on a new drug court, and that raises a fair question for families, taxpayers, and people in recovery. Will this help people with opioid use disorder get treatment faster, or will it pull money toward the justice system instead of care in the community? That question matters now because settlement funds are limited, overdose risk remains high, and every dollar spent one way cannot be spent somewhere else. I have covered opioid policy long enough to know this pattern. Governments often say they want treatment, then route money through systems built for control and punishment. Sometimes that works. Often, it falls short. So the real issue is not whether a drug court sounds helpful. It is whether this specific plan is the best use of scarce public money.

What stands out here

• Jefferson Parish is weighing a justice-based response with opioid settlement funds meant to address addiction harms.
• Drug courts can help some people, but outcomes depend on treatment access, rules, and who gets excluded.
• Public health experts often argue settlement money should first support low-barrier treatment, housing, and overdose prevention.
• The best test is simple. Will this spending reduce overdose deaths and connect more people to evidence-based care?

Why opioid settlement money draws so much scrutiny

Opioid settlements came from lawsuits against companies tied to the overdose crisis. The broad public expectation is straightforward. That money should go toward repairing damage from addiction, overdose, and untreated mental health needs.

And that is why people react strongly when funds move toward courts, jails, or policing. A drug court may offer treatment links, yes, but it still sits inside the criminal legal system. For many advocates, that is like trying to fix a collapsed roof by repainting the walls. You may improve one piece, but the structural problem remains.

Settlement spending gets the most support when it expands treatment people can reach without being arrested first.

How a drug court is supposed to work

A drug court is a supervised court program for people whose criminal cases are tied to substance use. In theory, participants get treatment, regular check-ins, drug testing, and judicial oversight instead of a standard path through jail or prison.

That model can help some people stay engaged in care. But the details matter more than the sales pitch. Does the court allow medications for opioid use disorder such as buprenorphine and methadone? Does it punish relapse harshly, even though relapse can be part of recovery? Does it focus on public health, or does it simply wrap treatment language around old court habits?

That distinction is non-negotiable.

Is a new drug court the best use of opioid settlement money?

Honestly, maybe not, at least not by default. The strongest case for using opioid settlement dollars is to fund services that people can access early, quickly, and without criminal charges hanging over their heads. That usually means medication treatment, mobile outreach, peer support, recovery housing, transportation help, and naloxone distribution.

Here is the thing. Drug courts reach only a slice of the population. They typically serve people already in the court system, and many programs have eligibility limits that screen out those with the most severe needs or the most complex legal histories. If the goal is broad overdose prevention, a court-based program may be too narrow.

But there is a counterargument worth taking seriously. If Jefferson Parish already has major gaps in court diversion, and if a new drug court is built around evidence-based treatment rather than sanctions, it could keep some people out of jail and move them toward recovery. That is a real benefit. The question is scale. How many people will it reach compared with other options?

What evidence should guide Jefferson Parish opioid settlement money decisions?

If parish leaders want public trust, they should publish a simple scorecard before spending starts. Not vague promises. Actual metrics.

1. How many people will the drug court serve each year?
2. How many participants will receive medications for opioid use disorder?
3. What share will complete the program?
4. How often will relapse trigger sanctions, jail time, or removal?
5. What is the cost per participant compared with community treatment programs?
6. Will the parish also fund naloxone, housing support, and low-barrier clinics?

Without those numbers, debate turns into branding. A new court can sound serious and orderly, which politicians often like, but overdose response should be judged by outcomes, not optics.

What critics of drug courts usually get right

Critics are not saying every drug court fails. They are saying the model can drift away from medical best practice. That concern is grounded in years of debate around addiction policy.

Some drug courts have resisted medications for opioid use disorder, even though medications like methadone and buprenorphine are widely recognized as the standard of care by agencies such as the Substance Abuse and Mental Health Services Administration and the Centers for Disease Control and Prevention. Others rely on sanctions that can punish people for symptoms of the disorder they are supposed to treat.

Look, if a court says it supports recovery but sidelines proven medication, that is not a treatment-first system. It is a dressed-up version of coercion.

What a smarter spending mix could look like

If I were judging this plan as a veteran reporter, I would ask whether the drug court is one part of a broader settlement strategy or whether it becomes the headline project because it is politically easier to sell. Those are not the same thing.

A stronger approach would spread opioid settlement money across several fronts:

• Medication treatment access through clinics, emergency departments, and primary care.
• Naloxone distribution for families, first responders, and community groups.
• Peer support and case management to help people stay in care after a crisis.
• Recovery housing and transportation help, because treatment fails when daily logistics collapse.
• Targeted diversion programs, including a drug court only if it follows medical evidence.

Think of it like building a basketball team. You do not spend the whole budget on one decent center and ignore guards, defense, and the bench. Addiction response works the same way. One program cannot carry the whole game.

Questions local residents should ask now

If you live in Jefferson Parish, push for specifics. Public meetings and budget documents should answer basic questions in plain English.

Ask about treatment standards

Will the court fully permit methadone and buprenorphine? Will participants be able to continue medications already prescribed to them? If the answer is fuzzy, that is a red flag.

Ask about who gets helped

Will the program serve people at high overdose risk, or only those most likely to succeed? Courts often look better on paper when they select easier cases (and that can hide weak policy choices).

Ask about the alternative

What could the same money fund outside the justice system? More clinic slots? More outreach workers? More naloxone in neighborhoods hit hardest by overdose? If leaders cannot answer that, they have not done the hard comparison work.

Where this should go next

Jefferson Parish may still decide a new drug court is worth funding. Fine. But opioid settlement money should meet a higher bar than political convenience or familiar bureaucracy. It should go where evidence, access, and urgency overlap.

If officials want to prove this is the right move, they should show the numbers, protect medication access, and fund community treatment at the same time. If they do not, residents should ask a blunt question. Why are we waiting for people to enter court before we help them?